LYNOZYFIC

Medicinal product

(Invented) name

LYNOZYFIC

Active substance (s)

Linvoseltamabas

Strength

5 mg

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

L01FX37, linvoseltamab

Marketing authorisation holder

Regeneron Ireland Designated Activity Company (DAC), Airija

Date of authorisation

2025-04-23

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Flakone (2,5 ml infuzinio tirpalo) yra:	2.5 ml
Linvoseltamabas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117333	103433	1103433	flakonas	2,5 ml N1		Receptinis	EU/1/25/1917	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-04-23	Registruotas